Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

iCAD VeraLook cleared

This article was originally published in The Gray Sheet

Executive Summary

Computer-aided detection system for computed tomography colonography has gained 510(k) clearance from FDA, iCAD reports Aug. 4. VeraLook can automatically identify polyps and streamline the image reading process, the firm said, noting a typical exam may contain 1,200-1,500 images per patient. Last year, CMS issued a national non-coverage decision for CT colonography, also known as virtual colonoscopy, for colorectal cancer screening (1"The Gray Sheet" May 18, 2009). iCAD also markets the SecondLook mammography CAD system

You may also be interested in...



Medicare Denies Coverage Of CT Colonography For Cancer Screening

The hopes of imaging equipment and software makers, the American Cancer Society and radiologists were dashed with CMS' final decision not to cover computed tomography colonography for colorectal cancer screening

Philips Portfolio Includes ‘No Single Product That Does Not Use A Type Of AI,’ Says CEO And AI Thought Leader Roy Jakobs

Philips CEO Roy Jakobs talks to Medtech Insight about the medtech firm’s decade-long history of embedding AI into its products and what he expects from the newly released draft framework by the National Academy of Medicine, which he helped develop as co-chair of the Steering Committee.

MoCRA Stakeholders Reminded Registration Enforcement Begins 1 July: ‘Do Not Delay!’

The Independent Beauty Association urged stakeholders at its Cosmetic Convergence Symposium to take action to ensure they are meeting requirements of the Modernization of Cosmetics Regulation Act come 1 July, when FDA’s enforcement of the facility and product registration deadline begins. Presenters offered tips from companies that have already completed the process.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel